X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Fulford India with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FULFORD INDIA vs MYLAN (US) - Comparison Results

FULFORD INDIA    Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 FULFORD INDIA   MYLAN
EQUITY SHARE DATA
    FULFORD INDIA
Mar-14
MYLAN
Dec-14
FULFORD INDIA/
MYLAN
5-Yr Chart
Click to enlarge
High Rs9424,066-   
Low Rs4502,865-   
Sales per share (Unadj.) Rs691.41,391.9-  
Earnings per share (Unadj.) Rs11.5167.7-  
Cash flow per share (Unadj.) Rs15.4269.9-  
Dividends per share (Unadj.) Rs2.000-  
Dividend yield (eoy) %0.30-  
Book value per share (Unadj.) Rs380.0691.9-  
Shares outstanding (eoy) m3.90378.37-   
Bonus/Rights/Conversions -OI-  
Price / Sales ratio x1.02.5 40.4%   
Avg P/E ratio x60.720.7 293.8%  
P/CF ratio (eoy) x45.312.8 352.9%  
Price / Book Value ratio x1.85.0 36.6%  
Dividend payout %17.40-   
Avg Mkt Cap Rs m2,7141,311,270 0.2%   
No. of employees `0000.425.0 1.8%   
Total wages/salary Rs m5050-   
Avg. sales/employee Rs Th6,073.021,066.3 28.8%   
Avg. wages/employee Rs Th1,137.40-   
Avg. net profit/employee Rs Th100.72,537.8 4.0%   
INCOME DATA
Net Sales Rs m2,696526,658 0.5%  
Other income Rs m125-3,070 -4.1%   
Total revenues Rs m2,822523,589 0.5%   
Gross profit Rs m-46130,982 -0.0%  
Depreciation Rs m1538,681 0.0%   
Interest Rs m1022,717 0.0%   
Profit before tax Rs m5466,515 0.1%   
Minority Interest Rs m0-273 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m102,797 0.3%   
Profit after tax Rs m4563,445 0.1%  
Gross profit margin %-1.724.9 -6.9%  
Effective tax rate %17.74.2 420.4%   
Net profit margin %1.712.0 13.8%  
BALANCE SHEET DATA
Current assets Rs m1,738463,002 0.4%   
Current liabilities Rs m545361,975 0.2%   
Net working cap to sales %44.319.2 230.8%  
Current ratio x3.21.3 249.5%  
Inventory Days Days4878 62.1%  
Debtors Days Days4107 4.0%  
Net fixed assets Rs m12121,841 0.0%   
Share capital Rs m3918,624 0.2%   
"Free" reserves Rs m1,4430-   
Net worth Rs m1,482261,801 0.6%   
Long term debt Rs m0391,105 0.0%   
Total assets Rs m2,0771,054,511 0.2%  
Interest coverage x6.73.9 171.0%   
Debt to equity ratio x01.5 0.0%  
Sales to assets ratio x1.30.5 260.0%   
Return on assets %2.68.2 31.9%  
Return on equity %3.024.2 12.4%  
Return on capital %4.313.6 31.6%  
Exports to sales %00-   
Imports to sales %24.50-   
Net fx Rs m-6560-   
CASH FLOW
From Operations Rs m9069,230 0.1%  
From Investments Rs m105-54,596 -0.2%  
From Financial Activity Rs m-14-18,242 0.1%  
Net Cashflow Rs m181-3,609 -5.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 68.22 Rs / USD

Compare FULFORD INDIA With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare FULFORD INDIA With: WOCKHARDT LTD.  DR. REDDYS LAB  PIRAMAL ENTERPRISES  SUVEN LIFE  ALKEM LABORATORIES  



Today's Market

Sensex Opens Higher; Consumer Durables & Bank Stocks Lead(09:30 am)

Asian share markets are lower today as Japanese and Hong Kong shares fall. The Nikkei 225 is off 0.8% while the Hang Seng is down 0.4%.

Related Views On News

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

After Vakrangee and Manpasand, More Auditors May Soon Resign. To Protect Your Wealth, Avoid these Stocks(The 5 Minute Wrapup)

Jun 8, 2018

The change in auditing regulations can bring a big change in corporate governance behaviour in the mid and small-cap space.

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Is Data Pointing Towards a Revival in the FMCG Sector?(Sector Info)

Jun 8, 2018

After several quarters of stress in the aftermath of demonetisation and the rollout of GST, this data is pointing towards revival in the India's rural FMCG industry.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FULFORD INDIA SHARE PRICE


Jul 30, 2015 (Close)

TRACK FULFORD INDIA

  • Track your investment in FULFORD INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FULFORD INDIA - PANACEA BIOTECH COMPARISON

COMPARE FULFORD INDIA WITH

MARKET STATS